Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus
IPS Journal of Biotechnology and Applied Biochemistry · 2026
DOI: 10.54117/ijbab.v2i2.204 ↗Kurz gefasst
Fachartikel in der Zeitschrift IPS Journal of Biotechnology and Applied Biochemistry, 2026. Verfasst von Irene Ngozi Okafor und 2 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study comparatively evaluated the quantitative phytochemical profiles, in vitro antidiabetic activities (α-amylase and α-glucosidase inhibition), and anti-inflammatory potential (bovine serum albumin denaturation inhibition) of aqueous extracts of four key medicinal plants: Vernonia amygdalina, Andrographis paniculata, Ocimum gratissimum, and Momordica charantia. Standard spectrophotometric and titrimetric assays were employed to quantify tannins, phytates, oxalates, alkaloids, and flavonoids. Inhibitory activity against carbohydrate-hydrolyzing enzymes (α-amylase and α-glucosidase) was benchmarked against Acarbose, while anti-inflammatory capacity was benchmarked against Diclofenac sodium using the protein denaturation assay across concentrations of 1 to 5 mg/mL. Phytochemical screening demonstrated high flavonoid levels in O. gratissimum (20.20%) and A. paniculata (15.02%), while high alkaloid levels were present in M. charantia (8.53%) and A. paniculata (7.27%). Anti-nutritional oxalate levels remained safely minimal across all species (0.205–0.292 mg/100g). In carbohydrate-hydrolyzing enzyme assay, V. amygdalina demonstrated superior α-amylase inhibition (IC50 = 1.21 mg/mL, surpassing Acarbose IC50 = 1.28 mg/mL) and potent α-glucosidase inhibition (IC50 = 0.35 mg/mL vs Acarbose IC50 = 0.30 mg/mL). O. gratissimum also exhibited notable α-glucosidase inhibition (IC50 = 2.18 mg/mL Furthermore, in the anti-inflammatory assay, M. charantia (IC50 = 0.43 mg/mL) and V. amygdalina (IC50 = 0.45 mg/mL) exhibited remarkable, superior protection against thermal protein denaturation compared to the standard anti-inflammatory drug Diclofenac sodium (IC50 = 0.88 mg/mL). V. amygdalina and M. charantia possess dual-action antidiabetic and anti-inflammatory properties, providing a strong pharmacological validation for their traditional formulation in managing diabetes mellitus and preventing associated inflammatory complications.
Zitieren
APA
Okafor, I. N., Christopher, E. C., & Egbe, R. C. (2026). Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus. IPS Journal of Biotechnology and Applied Biochemistry. https://doi.org/10.54117/ijbab.v2i2.204
Vancouver
Okafor IN, Christopher EC, Egbe RC. Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus. IPS Journal of Biotechnology and Applied Biochemistry. 2026. doi:10.54117/ijbab.v2i2.204
BibTeX
@article{Okafor2026,
author = {Okafor, Irene Ngozi and Christopher, Emmanuel Chisom and Egbe, Rita Chidimma},
title = {Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus},
journal = {IPS Journal of Biotechnology and Applied Biochemistry},
year = {2026},
doi = {10.54117/ijbab.v2i2.204}
}
EUVIMED